What's new in the treatment of serious MRSA infection?
Holmes NE, Howden BP.
Curr Opin Infect Dis · research support, non-u.s. gov't; review; journal article · DOI 10.1097/qco.0000000000000101 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för dalbavancin. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
18 träffarDalbavancin or oritavancin for skin infections.
Boucher HW, Talbot GH, Dunne MW.
N Engl J Med · letter; comment · DOI 10.1056/nejmc1407925Dalbavancin or oritavancin for skin infections.
Núñez-Núñez M, Rodríguez-Baño J.
N Engl J Med · letter; comment · DOI 10.1056/nejmc1407925Dalbavancin or oritavancin for skin infections.
Baang J, Fisher S.
N Engl J Med · letter; comment · DOI 10.1056/nejmc1407925Dalbavancin or oritavancin for skin infections.
Cormican M.
N Engl J Med · letter; comment · DOI 10.1056/nejmc1407925Dalbavancin or oritavancin for skin infections.
Corey GR, Jiang H, Moeck G.
N Engl J Med · letter; comment · DOI 10.1056/nejmc1407925Glycopeptide antibiotics: back to the future.
Butler MS, Hansford KA, Blaskovich MA, Halai R, Cooper MA.
J Antibiot (Tokyo) · research support, non-u.s. gov't; review; journal article · DOI 10.1038/ja.2014.111Pharmaceutical approval update.
Goldenberg MM.
P T · other; journal articleDalbavancin approved for acute skin infections.
Traynor K.
Am J Health Syst Pharm · news · DOI 10.2146/news140044Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Salem AH, Zhanel GG, Ibrahim SA, Noreddin AM.
Clin Exp Pharmacol Physiol · research support, non-u.s. gov't; journal article · DOI 10.1111/1440-1681.12195Once-weekly dalbavancin versus daily conventional therapy for skin infection.
Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW.
N Engl J Med · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1056/nejmoa1310480Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains.
Citron DM, Tyrrell KL, Goldstein EJ.
Diagn Microbiol Infect Dis · research support, non-u.s. gov't; journal article · DOI 10.1016/j.diagmicrobio.2014.05.014Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin.
Cheng M, Ziora ZM, Hansford KA, Blaskovich MA, Butler MS, Cooper MA.
Org Biomol Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1039/c3ob42428fMethicillin-resistant Staphylococcus aureus therapy: past, present, and future.
Rodvold KA, McConeghy KW.
Clin Infect Dis · historical article; research support, non-u.s. gov't; review; journal article · DOI 10.1093/cid/cit614Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.
Baldoni D, Furustrand Tafin U, Aeppli S, Angevaare E, Oliva A, Haschke M, Zimmerli W, Trampuz A.
Int J Antimicrob Agents · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2013.05.019Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains).
Jones RN, Stilwell MG.
Diagn Microbiol Infect Dis · journal article · DOI 10.1016/j.diagmicrobio.2013.01.002Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).
Jones RN, Sader HS, Flamm RK.
Diagn Microbiol Infect Dis · multicenter study; journal article · DOI 10.1016/j.diagmicrobio.2012.11.024[In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
Aktaş G, Bozdoğan B, Derbentli S.
Mikrobiyol Bul · journal article; english abstract